MARK MUNGER

Professor Emeritus

Pharmacotherapy

  • Professor Emeritus
    Pharmacotherapy

RESEARCH INTERESTS

  • Repurposing drugs to address major public health concerns, unique value propositions and differentiation, with the potential for commercial product value
  • Conducting research on the expanding use of medical cannabis in the State of Utah
  • Improving medication safety across the United States using an artificial intelligence system to identify pharmacokinetic, dynamic, and genomic interactions allowing actionable changes to patient drug profiles

GRANTS

  • EXTERNAL GRANT OR CONTRACT
    ASSESSMENT OF RILUZOLE TO REDUCE PAROXYSMAL EPISODES OF ATRIAL FIBRILLATION (THE SOLUTION STUDY)
    30 Dec 2021 - 30 Jun 2024
  • EXTERNAL GRANT OR CONTRACT
    MUNGER - ALSAM WITH DENVER
    UNIVERSITY OF COLORADO AT DENV1 Jan 2019 - 31 Dec 2022
    UNIVERSITY OF COLORADO AT DENV
  • EXTERNAL GRANT OR CONTRACT
    COMMUNITY PHARMACY SERVICES
    SKAGGS INSTITUTE FOR RESEARCH1 Jan 2015 - 31 Dec 2017
    SKAGGS INSTITUTE FOR RESEARCH
  • EXTERNAL GRANT OR CONTRACT
    PRIMARY CARE IN PHARMACIES
    SKAGGS FOUNDATION FOR RESEARCH11 Dec 2014 - 31 Dec 2018
    SKAGGS FOUNDATION FOR RESEARCH
  • EXTERNAL GRANT OR CONTRACT
    STATE INNOVATION MODEL GRANT
    UTAH DEPARTMENT OF HEALTH4 Jan 2013 - 31 Dec 2013
    UTAH DEPARTMENT OF HEALTH
  • EXTERNAL GRANT OR CONTRACT
    BARD EVAL SALINE SOLUTION
    BARD ACCESS SYSTEMS7 Sep 2012 - 10 May 2012
    BARD ACCESS SYSTEMS
  • EXTERNAL GRANT OR CONTRACT
    PHARMACY LISENSURE MP12023
    STATE OF UTAH7 Jan 2012 - 31 Dec 2013
    STATE OF UTAH
  • EXTERNAL GRANT OR CONTRACT
    CLINICAL STUDY CVEA489US501
    NOVARTIS PHARMACEUTICALS CORP8 Jan 2009 - 31 Dec 2010
    NOVARTIS PHARMACEUTICALS CORP
  • EXTERNAL GRANT OR CONTRACT
    RIBOSE EFFECTS ON CARDIAC PTS
    BIOENERGY INC4 Oct 2006 - 31 Dec 2007
    BIOENERGY INC
  • EXTERNAL GRANT OR CONTRACT
    AGELESS TRIAL
    NOVARTIS PHARMACEUTICALS CORP2 Mar 2006 - 2 Aug 2008
    NOVARTIS PHARMACEUTICALS CORP
  • EXTERNAL GRANT OR CONTRACT
    CSPP100A2327
    NOVARTIS PHARMACEUTICALS CORP12 Dec 2005 - 31 Dec 2006
    NOVARTIS PHARMACEUTICALS CORP
  • EXTERNAL GRANT OR CONTRACT
    SAFETY & EFFICACY OF ALISKIREN
    NOVARTIS PHARMACEUTICALS CORP4 Jan 2005 - 12 Jan 2006
    NOVARTIS PHARMACEUTICALS CORP
  • EXTERNAL GRANT OR CONTRACT
    ALISKIREN/VALSARTAN
    NOVARTIS PHARM CORP2 Dec 2004 - 2 Jan 2006
    NOVARTIS PHARM CORP
  • EXTERNAL GRANT OR CONTRACT
    ALISKREN HYPERTENSION STUDY
    NOVARTIS PHARM CO5 Dec 2003 - 31 Dec 2004
    NOVARTIS PHARM CO
  • EXTERNAL GRANT OR CONTRACT
    RIBOSE/ASSESS LIFE QUALITY
    BIOENERGY INC11 Jan 2003 - 31 Dec 2004
    BIOENERGY INC
  • EXTERNAL GRANT OR CONTRACT
    PEAK EXERCISE TOLERANCE
    AMER COLLEGE OF CLINICAL PHARM7 Jan 2003 - 31 Dec 2004
    AMER COLLEGE OF CLINICAL PHARM
  • EXTERNAL GRANT OR CONTRACT
    ACCOMPLISH
    NOVARTIS PHARMACEUTICALS CORP6 Jan 2003 - 6 Jan 2009
    NOVARTIS PHARMACEUTICALS CORP
  • EXTERNAL GRANT OR CONTRACT
    NATEGLINIDE CALSARTAN IGT
    NOVARTIS PHARMACEUTICALS CORP12 Jan 2001 - 9 Jan 2010
    NOVARTIS PHARMACEUTICALS CORP
  • EXTERNAL GRANT OR CONTRACT
    VALSARTAN/ENDOTHELIAL FUNCTION
    NOVARTIS PHARM CO12 Jan 2001 - 31 Dec 2004
    NOVARTIS PHARM CO
  • EXTERNAL GRANT OR CONTRACT
    CANDESARTAN CILEXETIL+LISINOPR
    ASTRA-ZENECA PHARMACEUTICAL CO6 Jan 2001 - 31 Dec 2002
    ASTRA-ZENECA PHARMACEUTICAL CO
  • EXTERNAL GRANT OR CONTRACT
    OMAPATRILAT VS ENALAPRIL (OCTA
    BRISTOL-MEYERS SQUIBB (PPD DEV10 Jan 2000 - 1 Jan 2002
    BRISTOL-MEYERS SQUIBB (PPD DEV
  • FELLOWSHIP OR RESIDENCY
    AFPE FELLOW CHEANG
    AMER FNDN FOR PHARM ED9 Jan 2000 - 31 Dec 2001
    AMER FNDN FOR PHARM ED
  • EXTERNAL GRANT OR CONTRACT
    BMS207940/HEART FAILURE
    BRISTOL MEYERS SQUIBB6 Jan 2000 - 31 Dec 2001
    BRISTOL MEYERS SQUIBB
  • EXTERNAL GRANT OR CONTRACT
    OPERA STUDY
    BRISTOL-MEYERS SQUIBB1 Jan 2000 - 31 Dec 2005
    BRISTOL-MEYERS SQUIBB
  • EXTERNAL GRANT OR CONTRACT
    SIMVASTATIN TISSUE FACTOR EXP
    MERCK & COMPANY INC1 Jan 2000 - 31 Dec 2007
    MERCK & COMPANY INC